Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Dexmedetomidine in Septic Shock
NCT07470775Phase 4Not yet recruiting
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Mar 2026
- Primary completion
- Mar 2028
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial in septic shock comparing Placebo with Dexmedetomidine (2 arms). Primary endpoint: Heart Rate Variability at 48 hours. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT07470775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07470775.